GILEAD SCIENCES, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
GILEAD SCIENCES, INC. (GILD) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $5.00 billion for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-09
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $5.00B, a 21.58% decline year-over-year.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $5.84B, a 19.11% decline year-over-year.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.40B, a 13.54% decline year-over-year.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $7.05B, a 7.91% decline year-over-year.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $25.66B, a 14.33% decline from fiscal 2016.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $29.95B, a 6.84% decline from fiscal 2015.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $32.15B, a 31.37% increase from fiscal 2014.
- GILEAD SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $24.47B, a 126.53% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $5.00B 10-Q · filed 2018-05-09 | $10.84B derived: sum of 2 quarters · filed 2018-05-09 | $17.24B derived: sum of 3 quarters · filed 2018-05-09 | $24.29B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $5.84B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $12.24B derived: sum of 2 quarters · filed 2018-02-27 | $19.29B derived: sum of 3 quarters · filed 2018-02-27 | $25.66B 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $6.40B 10-Q · filed 2017-11-07 | $13.45B derived: sum of 2 quarters · filed 2017-11-07 | $19.82B 10-Q · filed 2017-11-07 | $27.04B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $7.05B 10-Q · filed 2017-08-07 | $13.42B 10-Q · filed 2017-08-07 | $20.64B derived: sum of 3 quarters · filed 2018-05-09 | $28.04B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | $6.38B 10-Q · filed 2018-05-09 | $13.59B derived: sum of 2 quarters · filed 2018-05-09 | $21.00B derived: sum of 3 quarters · filed 2018-05-09 | $28.65B derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $7.22B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $14.62B derived: sum of 2 quarters · filed 2018-02-27 | $22.27B derived: sum of 3 quarters · filed 2018-02-27 | $29.95B 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $7.41B 10-Q · filed 2017-11-07 | $15.06B derived: sum of 2 quarters · filed 2017-11-07 | $22.74B 10-Q · filed 2017-11-07 | $31.15B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $7.65B 10-Q · filed 2017-08-07 | $15.33B 10-Q · filed 2017-08-07 | $23.74B derived: sum of 3 quarters · filed 2018-02-27 | $31.95B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $7.68B 10-Q · filed 2017-05-10 | $16.09B derived: sum of 2 quarters · filed 2018-02-27 | $24.30B derived: sum of 3 quarters · filed 2018-02-27 | $32.43B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $8.41B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $16.62B derived: sum of 2 quarters · filed 2018-02-27 | $24.75B derived: sum of 3 quarters · filed 2018-02-27 | $32.15B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $8.21B 10-Q · filed 2016-11-07 | $16.34B derived: sum of 2 quarters · filed 2016-11-07 | $23.74B 10-Q · filed 2016-11-07 | $30.96B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $8.13B 10-Q · filed 2016-08-05 | $15.53B 10-Q · filed 2016-08-05 | $22.75B derived: sum of 3 quarters · filed 2017-02-27 | $28.72B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $7.41B 10-Q · filed 2016-05-06 | $14.63B derived: sum of 2 quarters · filed 2017-02-27 | $20.59B derived: sum of 3 quarters · filed 2017-02-27 | $27.01B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $7.22B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $13.19B derived: sum of 2 quarters · filed 2017-02-27 | $19.60B derived: sum of 3 quarters · filed 2017-02-27 | $24.47B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $5.97B 10-Q · filed 2015-11-04 | $5.97B 10-Q · filed 2014-11-05 | $12.38B derived: sum of 2 quarters · filed 2015-11-04 | $17.25B 10-Q · filed 2015-11-04 | $17.25B 10-Q · filed 2014-11-05 | $20.30B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $6.41B 10-Q · filed 2015-08-05 | $6.41B 10-Q · filed 2014-08-04 | $11.28B 10-Q · filed 2015-08-05 | $11.28B 10-Q · filed 2014-08-04 | $14.33B derived: sum of 3 quarters · filed 2016-02-24 | $17.04B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $4.87B 10-Q · filed 2015-05-08 | $4.87B 10-Q · filed 2014-05-07 | $7.91B derived: sum of 2 quarters · filed 2016-02-24 | $10.62B derived: sum of 3 quarters · filed 2016-02-24 | $13.28B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $3.04B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $5.75B derived: sum of 2 quarters · filed 2016-02-24 | $8.41B derived: sum of 3 quarters · filed 2016-02-24 | $10.80B 10-K · filed 2016-02-24 | $10.80B 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $2.71B 10-Q · filed 2014-11-05 | $5.37B derived: sum of 2 quarters · filed 2014-11-05 | $7.76B 10-Q · filed 2014-11-05 | $10.27B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $2.66B 10-Q · filed 2014-08-04 | $5.05B 10-Q · filed 2014-08-04 | $7.56B derived: sum of 3 quarters · filed 2015-02-25 | $9.92B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $2.39B 10-Q · filed 2014-05-07 | $4.90B derived: sum of 2 quarters · filed 2015-02-25 | $7.26B derived: sum of 3 quarters · filed 2015-02-25 | $9.58B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $2.51B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $4.87B derived: sum of 2 quarters · filed 2015-02-25 | $7.19B derived: sum of 3 quarters · filed 2015-02-25 | $9.40B 10-K · filed 2015-02-25 | $9.40B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $2.36B 10-Q · filed 2013-10-31 | $4.68B derived: sum of 2 quarters · filed 2013-10-31 | $6.89B 10-Q · filed 2013-10-31 | $9.02B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $2.32B 10-Q · filed 2013-08-01 | $4.53B 10-Q · filed 2013-08-01 | $6.66B derived: sum of 3 quarters · filed 2014-02-25 | $8.73B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $2.21B 10-Q · filed 2013-05-08 | $4.34B derived: sum of 2 quarters · filed 2014-02-25 | $6.41B derived: sum of 3 quarters · filed 2014-02-25 | $8.45B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $2.13B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $4.20B derived: sum of 2 quarters · filed 2014-02-25 | $6.24B derived: sum of 3 quarters · filed 2014-02-25 | $8.10B 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $2.07B 10-Q · filed 2012-11-06 | $4.11B derived: sum of 2 quarters · filed 2012-11-06 | $5.97B 10-Q · filed 2012-11-06 | $7.90B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $2.04B 10-Q · filed 2012-08-01 | $3.90B 10-Q · filed 2012-08-01 | $5.83B derived: sum of 3 quarters · filed 2013-02-27 | $7.70B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $1.86B 10-Q · filed 2012-05-04 | $3.79B derived: sum of 2 quarters · filed 2013-02-27 | $5.66B derived: sum of 3 quarters · filed 2013-02-27 | $7.47B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $3.80B derived: sum of 2 quarters · filed 2013-02-27 | $5.60B derived: sum of 3 quarters · filed 2013-02-27 | $7.39B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $1.87B 10-Q · filed 2011-11-04 | $3.67B derived: sum of 2 quarters · filed 2011-11-04 | $5.46B 10-Q · filed 2011-11-04 | $7.26B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $1.81B 10-Q · filed 2011-08-05 | $3.59B 10-Q · filed 2011-08-05 | $5.40B derived: sum of 3 quarters · filed 2012-02-23 | $7.05B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $1.79B 10-Q · filed 2011-05-09 | $3.59B derived: sum of 2 quarters · filed 2012-02-23 | $5.24B derived: sum of 3 quarters · filed 2012-02-23 | $6.81B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $1.80B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $3.45B derived: sum of 2 quarters · filed 2012-02-23 | $5.02B derived: sum of 3 quarters · filed 2012-02-23 | $6.47B 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $1.65B 10-Q · filed 2010-11-08 | $3.22B derived: sum of 2 quarters · filed 2010-11-08 | $4.66B 10-Q · filed 2010-11-08 | $6.05B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $1.57B 10-Q · filed 2010-08-09 | $3.02B 10-Q · filed 2010-08-09 | $4.40B derived: sum of 3 quarters · filed 2011-02-28 | $5.74B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $1.45B 10-Q · filed 2010-05-10 | $2.84B derived: sum of 2 quarters · filed 2011-02-28 | $4.17B derived: sum of 3 quarters · filed 2011-02-28 | $5.39B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $2.73B derived: sum of 2 quarters · filed 2011-02-28 | $3.94B derived: sum of 3 quarters · filed 2011-02-28 | $5.08B 10-K · filed 2011-02-28 | ||||
| 2008-09-30 | $1.34B 10-Q · filed 2009-11-05 | $2.56B derived: sum of 2 quarters · filed 2009-11-05 | $3.70B 10-Q · filed 2009-11-05 | |||||
| 2008-06-30 | $1.22B 10-Q · filed 2009-08-05 | $2.36B 10-Q · filed 2009-08-05 | ||||||
| 2007-12-31 | $3.73B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |